These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 21379576)
1. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms. Li X; Wu X; Camacho R; Schwartz GJ; LeRoith D PLoS One; 2011 Feb; 6(2):e17058. PubMed ID: 21379576 [TBL] [Abstract][Full Text] [Related]
2. Central infusion of ketone bodies modulates body weight and hepatic insulin sensitivity by modifying hypothalamic leptin and insulin signaling pathways in type 2 diabetic rats. Park S; Kim DS; Daily JW Brain Res; 2011 Jul; 1401():95-103. PubMed ID: 21652033 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Kim H; Haluzik M; Asghar Z; Yau D; Joseph JW; Fernandez AM; Reitman ML; Yakar S; Stannard B; Heron-Milhavet L; Wheeler MB; LeRoith D Diabetes; 2003 Jul; 52(7):1770-8. PubMed ID: 12829645 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus. Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827 [TBL] [Abstract][Full Text] [Related]
5. Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep. Laker RC; Henry BA; Wadley GD; Clarke IJ; Canny BJ; McConell GK Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R511-8. PubMed ID: 21148475 [TBL] [Abstract][Full Text] [Related]
6. Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice. Levi J; Huynh FK; Denroche HC; Neumann UH; Glavas MM; Covey SD; Kieffer TJ Diabetologia; 2012 Mar; 55(3):752-62. PubMed ID: 22202803 [TBL] [Abstract][Full Text] [Related]
8. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. Hidaka S; Yoshimatsu H; Kondou S; Tsuruta Y; Oka K; Noguchi H; Okamoto K; Sakino H; Teshima Y; Okeda T; Sakata T FASEB J; 2002 Apr; 16(6):509-18. PubMed ID: 11919153 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling. Park S; Hong SM; Sung SR; Jung HK Endocrinology; 2008 Feb; 149(2):445-54. PubMed ID: 17991727 [TBL] [Abstract][Full Text] [Related]
10. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice. Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469 [TBL] [Abstract][Full Text] [Related]
11. Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes. Zhao H; Yakar S; Gavrilova O; Sun H; Zhang Y; Kim H; Setser J; Jou W; LeRoith D Diabetes; 2004 Nov; 53(11):2901-9. PubMed ID: 15504971 [TBL] [Abstract][Full Text] [Related]
12. Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats. Park S; Kang S; Lee HW; Ko BS Neuroendocrinology; 2012; 95(4):332-43. PubMed ID: 22441304 [TBL] [Abstract][Full Text] [Related]
13. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Toyoshima Y; Gavrilova O; Yakar S; Jou W; Pack S; Asghar Z; Wheeler MB; LeRoith D Endocrinology; 2005 Sep; 146(9):4024-35. PubMed ID: 15947005 [TBL] [Abstract][Full Text] [Related]
14. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats. Park S; Hong SM; Ahn IS Neuroendocrinology; 2009; 89(4):387-99. PubMed ID: 19176946 [TBL] [Abstract][Full Text] [Related]
15. Central Sfrp5 regulates hepatic glucose flux and VLDL-triglyceride secretion. Li Y; Tian M; Yang M; Yang G; Chen J; Wang H; Liu D; Wang H; Deng W; Zhu Z; Zheng H; Li L Metabolism; 2020 Feb; 103():154029. PubMed ID: 31770545 [TBL] [Abstract][Full Text] [Related]
16. Chronic central leptin decreases food intake and improves glucose tolerance in diet-induced obese mice independent of hypothalamic malonyl CoA levels and skeletal muscle insulin sensitivity. Keung W; Palaniyappan A; Lopaschuk GD Endocrinology; 2011 Nov; 152(11):4127-37. PubMed ID: 21914780 [TBL] [Abstract][Full Text] [Related]
17. A ketogenic diet impairs energy and glucose homeostasis by the attenuation of hypothalamic leptin signaling and hepatic insulin signaling in a rat model of non-obese type 2 diabetes. Park S; Kim DS; Kang S; Daily JW Exp Biol Med (Maywood); 2011 Feb; 236(2):194-204. PubMed ID: 21321316 [TBL] [Abstract][Full Text] [Related]
19. Effects of hepatic glycogen on food intake and glucose homeostasis are mediated by the vagus nerve in mice. López-Soldado I; Fuentes-Romero R; Duran J; Guinovart JJ Diabetologia; 2017 Jun; 60(6):1076-1083. PubMed ID: 28299379 [TBL] [Abstract][Full Text] [Related]
20. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats. Cummings BP; Bettaieb A; Graham JL; Stanhope KL; Dill R; Morton GJ; Haj FG; Havel PJ Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14670-5. PubMed ID: 21873226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]